Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20141209020258N128
IRCT20141209020258N128
Completed
Phase 3

Evaluation of the effect of Methylphenidate on consciousness in patients ?with brain damage in IC

Arak University of Medical Sciences0 sites90 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsBrain damage.Unspecified brain damage due to birth injuryP11.2

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Brain damage.
Sponsor
Arak University of Medical Sciences
Enrollment
90
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •A level of consciousness less than 10
  • •Being intuitive
  • •Ages between 16 and 50 years
  • •History of brain injury
  • •Absence of spacer lesion in brain scan (hematoma, tumor)
  • •No history of seizures
  • •No addiction to psychotropic substances and drugs
  • •No history of amphetamine use
  • •No history of hypertension, ischemic heart disease and diabetes mellitus
  • •Heart rate less than 120 times per minute

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 4
Effect of Methylphenidate on understanding intentionality in ADHD childre
IRCT20201103049254N1Tehran University of Medical Sciences20
Recruiting
Phase 3
Investigating the effect of methylphenidate on the level of consciousness in loss of consciousness patients due to poisoning
IRCT20220305054196N4Shahid Beheshti University of Medical Sciences64
Not yet recruiting
Phase 3
Investigating the effect of methylphenidate on increasing the level of consciousness in patients with hypoxic ischemic encephalopathy
IRCT20220924056025N1Qazvin Medical Sciences Research Deputy48
Recruiting
Phase 2
The effects of methylphenidate and atomoxetine on emotional intelligence, executive function and self-efficacy of 12-18-year-old adolescents with ADHD
IRCT20160523028008N31Hamedan University of Medical Sciences76
Not yet recruiting
Phase 4
Methylphenidate in Adults with Severe Traumatic brain injury for the Enhancement of Recovery (MASTER)Traumatic brain injuryPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationInjuries and Accidents - Other injuries and accidents
ACTRN12615001044516Royal Rehab20